Research

March 23, 2017

Breast cancer program lands new research grants

Several investigators in Vanderbilt-Ingram Cancer Center’s (VICC) Breast Cancer Program have received grant awards to support translational research that may improve disease outcomes for patients.

By VUMC News and Communications
A large audience wearing 3D glasses in a darkened movie theater.
March 23, 2017

Study takes 3-D perspective on colorectal cancer

Despite dramatic recent advances in treatment, colorectal cancer killed more than 49,000 Americans last year, according to the National Cancer Institute, making it the second most lethal malignancy after cancers of the lung and bronchus.

By Bill Snyder
March 22, 2017

Blocking neuroblastoma cell growth

An inhibitor of cell metabolism may be a good therapeutic target for neuroblastoma, which accounts for about 15 percent of pediatric cancer-related deaths.

By Leigh MacMillan
March 20, 2017

Delirium in the ED

Interventions for delirium in the emergency department setting are needed to preserve patients’ long-term function and cognition, Vanderbilt investigators have found.

By Laura Daniel
March 17, 2017

New target for colorectal cancer

Vanderbilt investigators have discovered that activated epidermal growth factor receptor may be a target for therapies to prevent colorectal cancer development.

By VUMC News and Communications
bright yellow water pump
March 16, 2017

Study catches ‘notorious’ drug pump in action

Researchers at Vanderbilt University Medical Center (VUMC) have mapped the conformational changes that occur in a protein “notorious” for pumping chemotherapeutic drugs out of cancer cells and blocking medications from reaching the central nervous system.

By Bill Snyder
March 16, 2017

VUMC joins cutting-edge obesity research network

Vanderbilt University Medical Center (VUMC) is one of four centers receiving a $15 million, four-year research award from the American Heart Association (AHA) to provide cutting-edge research on obesity as part of its sixth Strategically Focused Research Network (SFRN).
By Craig Boerner
March 16, 2017

Premature infants in NICU do better with touch: study

Treatment in the Neonatal Intensive Care Unit (NICU) saves millions of infants born prematurely every year. But treatment is not without cost. Painful procedures such as needle pricks can impact early brain development.
By Bill Snyder
March 16, 2017

Esophageal cancer complexities

New findings that reveal complex interactions in esophageal adenocarcinoma could lead to diagnostic, prognostic or therapeutic biomarkers.
By VUMC News and Communications
March 9, 2017

Study explores alcohol use patterns in early pregnancy

The latest Centers for Disease Control and Prevention update recommending that women who are pregnant or could become pregnant abstain from alcohol use prompted a Vanderbilt professor of Obstetrics and Gynecology and her team to explore the patterns of alcohol use in early pregnancy.
By Jessica Pasley
March 9, 2017

Certain risk factors linked to post-surgery infection

Plastic surgeons at Vanderbilt University Medical Center (VUMC) have published a prospective study that proves there are specific risk factors — such as obesity, smoking and diabetes — that contribute to development of a major surgical site infection following cosmetic surgery.
By Jill Clendening
March 9, 2017

Investigators use machine learning to predict suicide risk

According to the Centers for Disease Control and Prevention (CDC), in 2013 there were 41,149 suicides in the U.S., making it the 10th leading cause of death that year. Among high school students in 2013, the CDC estimates that over the previous 12 months 2.7 percent had sometime made a suicide attempt resulting in injury, poisoning or overdose that required medical attention.
By Paul Govern
March 9, 2017

Melanoma study finds new way to enhance targeted therapies

With the help of a drug formerly used to treat HIV/AIDS, researchers at Vanderbilt University Medical Center (VUMC) have found a way to make melanoma cells more vulnerable to targeted anti-cancer therapy.
By Bill Snyder